Purchases are not available yet. You can browse the site and sign in.
Psilocybin Serotonin Syndrome: MAOIs & Tramadol · Microdosing College
Safety
Psilocybin Serotonin Syndrome: MAOIs, Tramadol and Stacking Serotonergic Drugs
By Microdosing College Editorial·Last updated October 10, 2026·8 min read
When people ask about psilocybin serotonin syndrome, the honest answer is that the risk is usually low for psilocybin used alone — but it rises, sometimes sharply, the moment psilocybin is stacked on top of other serotonin-boosting drugs. Psilocybin's active metabolite, psilocin, works mainly by switching on the brain's serotonin 5-HT2A receptor. Add a second drug that floods the system with serotonin — a monoamine oxidase inhibitor (MAOI), tramadol, an SSRI or SNRI — and you are layering serotonergic effects, which is precisely the combination that can tip into serotonin toxicity.
This is a cluster guide within our broader microdosing safety hub. It is not medical advice, and it never tells you a combination is "safe." It explains how serotonin toxicity can arise, which drugs raise the concern, and the specific symptoms that mean stop and get help now. If you are weighing microdosing while taking any medication, screen first with our self-screener and talk to a clinician before anything else.
What serotonin syndrome actually is
Serotonin syndrome — more precisely serotonin toxicity — is a potentially life-threatening reaction caused by too much serotonin activity in the nervous system. It is not an allergy or an idiosyncratic quirk; it is a dose-dependent overshoot, and it almost always involves more than one serotonergic agent, or a very high dose of one.
According to a clinician reference from Patient.info on serotonin syndrome, the drugs most commonly implicated are MAOIs, SNRIs and SSRIs, with other triggers including tramadol, pethidine, fentanyl, dextromethorphan, lithium, St John's wort, and recreational drugs such as MDMA and LSD. The same reference notes that symptoms usually appear within about six hours of taking the provoking drug — which is exactly the window in which a psilocybin dose is active.
The classic clinical picture is a triad:
Autonomic instability — fast heart rate, high blood pressure, heavy sweating, fever, dilated pupils.
Altered mental state — anxiety, agitation, confusion, and in severe cases delirium or unconsciousness.
Why psilocybin plus a serotonergic drug is the real risk
Here is the part that gets oversimplified in both directions. Psilocybin on its own is, by the serotonin-toxicity literature, a relatively low-risk serotonergic — classic psychedelics like psilocybin, LSD and DMT are generally considered to carry a low risk of serotonin toxicity when used by themselves. That is the nuance the scare headlines miss. But "low risk alone" is not "no risk when combined."
The University of California, San Francisco's Translational Research on Psychedelics program states plainly that because psychedelics activate serotonin receptors, "they can lead to a life threatening condition called Serotonin Syndrome if used in conjunction with other medications or substances that also increase Serotonin levels in the brain," and that psychedelics are contraindicated in people taking SSRI or MAO-I antidepressants who cannot be weaned off them first.
Two drug classes deserve specific attention:
MAOIs (such as phenelzine, tranylcypromine, isocarboxazid, and the reversible MAOI moclobemide). MAOIs block the enzyme that breaks serotonin down, so the brain's serotonin levels are already elevated. Adding a serotonin-receptor agonist on top is a textbook high-risk pairing. MAOIs also unpredictably alter and prolong the psilocybin experience itself.
Tramadol, an opioid painkiller that is also a serotonin-norepinephrine reuptake inhibitor and lowers the seizure threshold. It is one of the most frequently named non-antidepressant triggers of serotonin toxicity, and combining it with any additional serotonergic agent is widely discouraged.
What the case evidence shows
We should be precise about evidence rather than alarmist. There is no large database of psilocybin-induced serotonin syndrome — but documented cases do exist when psilocybin is layered onto strong serotonergic medication.
In a 2024 case report in the Primary Care Companion for CNS Disorders, Baweja and colleagues described a 35-year-old woman taking high-dose venlafaxine (an SNRI) plus bupropion who was also taking recreational psilocybin microdoses four times a week; when trazodone was added, she developed serotonin toxicity within two days — diaphoresis, tremor, flushing, spontaneous and ocular clonus, nausea, raised blood pressure and a heart rate of 122 — meeting the Hunter criteria for serotonin toxicity (Baweja et al., 2024). The authors' own conclusion is the key teaching point: the risk "is thought to be low" with psilocybin plus standard antidepressants, "however, utilizing high doses of these psychotropics with unregulated doses of psilocybin may place the patient at an elevated risk."
That is the whole message of this guide in one sentence: it is the stacking, the high doses, and the unregulated nature of self-sourced psilocybin that turn a theoretical concern into a clinical event.
It is also worth knowing the flip side. A Johns Hopkins survey by Gukasyan and colleagues found that SSRIs and SNRIs frequently blunt psilocybin's effects, and that this dampening can persist for up to three months after stopping the antidepressant (Gukasyan et al., 2023, Journal of Psychopharmacology). The danger here is behavioural: someone who feels "nothing" from a microdose may be tempted to redose upward, unwittingly pushing the combined serotonergic load higher. We cover that interaction in depth in our psilocybin and SSRI interaction guide.
The drugs to flag before microdosing
The following are the serotonergic and serotonin-toxicity-relevant medications to identify before considering psilocybin. This is not exhaustive, and only a clinician who knows your full medication list can judge your specific situation.
Drug or class
Examples
Why it matters with psilocybin
MAOIs
Phenelzine, tranylcypromine, moclobemide
Already raise serotonin; high-risk combination, and unpredictably prolong effects
Tramadol
Tramadol, tapentadol
Serotonergic opioid; common serotonin-toxicity trigger; lowers seizure threshold
SSRIs / SNRIs
Sertraline, fluoxetine, venlafaxine, duloxetine
Add serotonergic load; can also blunt effects, prompting risky redosing
Other serotonergics
St John's wort, dextromethorphan, lithium, MDMA, trazodone, mirtazapine
Each adds to total serotonin activity; stacking compounds the risk
For a fuller, printable rundown of what to check, use our microdosing drug interactions checklist. MAOIs in particular usually require a supervised washout period before any serotonergic substance — never something to improvise.
Warning signs: when to stop and seek urgent care
If you have taken psilocybin and develop the following, treat it as an emergency. Serotonin toxicity can escalate within hours.
Agitation, restlessness or confusion that feels different from an expected psychedelic headspace.
Racing or pounding heart, high blood pressure, or chest discomfort.
Heavy sweating, flushing, or fever — a rising body temperature is a red flag for severe toxicity.
Tremor, muscle twitching or jerking (clonus), stiffness, or overactive reflexes.
Nausea, vomiting, or diarrhoea alongside any of the above.
If several of these appear together after combining psilocybin with any serotonergic drug, stop, do not take more, and seek emergency medical care — call your local emergency number. Tell clinicians exactly what was taken; serotonin toxicity is treatable, and early recognition matters. Removing the offending agents plus supportive care (and, in moderate cases, the antidote cyproheptadine) is the mainstay of management per the Patient.info serotonin syndrome reference. If you are in distress or unsure where to turn, our crisis resources list immediate support options.
Nothing in this article is a recommendation to combine substances. No drug, and no combination, is ever simply "safe." The responsible path when any serotonergic medication is in the picture is to screen with our self-screener, read the wider microdosing safety hub, and have a clinician — not a forum thread — make the call.
Can psilocybin cause serotonin syndrome on its own?+
The risk from psilocybin used alone appears low — classic psychedelics are generally considered low-risk for serotonin toxicity. The concern rises sharply when psilocybin is combined with other serotonergic drugs such as MAOIs, tramadol, SSRIs or SNRIs, especially at high or unregulated doses.
Is it dangerous to microdose psilocybin while taking an MAOI?+
MAOIs are flagged as a high-risk combination. They already raise serotonin levels by blocking its breakdown, and adding a serotonin-receptor agonist on top is a textbook serotonin-toxicity pairing. MAOIs also unpredictably prolong psilocybin's effects. This is a clinician-only decision, typically requiring a supervised washout.
What are the warning signs of serotonin toxicity after dosing?+
Agitation or confusion, a racing heart, high blood pressure, heavy sweating, fever, tremor, muscle twitching or jerking (clonus), rigidity and overactive reflexes — often within about six hours. If several appear together, stop, take no more, and seek emergency medical care.
Does tramadol interact with psilocybin?+
Tramadol is a serotonergic opioid and one of the most common non-antidepressant triggers of serotonin toxicity; it also lowers the seizure threshold. Combining it with psilocybin or any other serotonergic agent is widely discouraged. Discuss any pain medication with your clinician before considering microdosing.
I take an SSRI and feel nothing from a microdose — should I take more?+
No. SSRIs and SNRIs often blunt psilocybin's effects, sometimes for months after stopping (Gukasyan et al., 2023). Redosing upward to chase an effect raises your total serotonergic load and the toxicity risk. Do not increase the dose; speak to a clinician instead.
This guide is general educational information about microdosing, not medical advice and not a recommendation to use any substance. It can't account for your personal health. If you take medication or live with a mental-health condition, speak with a qualified professional before making any decision.
